Central line catheterisation plays a crucial role in prolonged treatment in children. Totally implantable venous access devices (TIVADs) are associated with a lower risk of thrombosis and are perceived by patients as more comfortable to use. The catheterisation is most commonly performed through the internal jugular vein or the subclavian vein. The present article shows the cases of two patients in whom atypical placement of a TIVAD was used. The first patient underwent TIVAD placement via femoral vein due to tumour mass in the thoracic cavity and thrombotic stenosis of both jugular and subcostal veins. In the second case, atypical localisation applied to the placement of a reservoir in the left parasternal region. In both patients, the atypical placement of TIVAD resulted in prolonged patency and provided access for further treatment.
The first well-documented case of the duodenal diverticulum (DD) was presented by Morgagni in 1762. In 1913 Case presented four cases of radiologically diagnosed DD. The first surgical resection of the duodenal diverticulum took place in 1915 and was performed by Key. The aetiology of the duodenal diverticula is not clear and remains controversial. The existence of the locus minoris resistentiae in the duodenal wall may be the place of mucosal or submucosal tissue layer herniation through the muscular defect. Duodenum is the second most common location of diverticula in the gastrointestinal tract. They appear in about 23% of the population and are rarely found in children. Surgical treatment is applied only if complications occur. We present a case of a 17-year-old female treated surgically with the use of a minimally invasive laparoscopic method combined with endoscopic control of the surgical field.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.